Eupraxia Pharmaceuticals Inc. (X43)
Market Open
12 Jun, 13:19
XSTU 
€
5. 10
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
3,000 Volume
- Eps
€ 5.1
Previous Close Want to track X43 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eupraxia Pharmaceuticals Inc. (X43) Statistics
Valuation metrics
Market Cap -
Enterprise value -80.41M
Trailing P/E (ttm) -5.29
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA 2.19
Overview
Shares outstanding 51.94M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 6
Average volume (90 days) 2
Price summary
52-Week low 3.28
52-Week high 7.5
Beta -
50-Day moving average 6.04
200-Day moving average 5.66
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.45%
Return on equity -0.48%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -38.58M
Diluted EPS (ttm) -1.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 80.56M
Total cash per share (mrq) -
Total debt (mrq) 154.36K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 15.12%
Book value per share (mrq) -
Cash Flow
Cash flow statement -27.48M
Levered free cash flow (LFCF) -38.58M
